Cardiovascular risk factors in patients with bicuspid aortic valve

Autor:	Okólska M; Cardiological Outpatient Clinic, John Paul II Hospital, Cracow, Poland., Róg B; Cardiological Outpatient Clinic, John Paul II Hospital, Cracow, Poland., Sałapa K; Department of Bioinformatics and Telemedicine, Jagiellonian University, Cracow, Poland., Tomkiewicz-Pająk L; Institute of Cardiology, Jagiellonian University Medical College, John Paul II Hospital, Cracow, Poland.
Jazyk:	polština
Zdroj:	Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego [Pol Merkur Lekarski] 2019 Feb 28; Vol. 46 (272), pp. 60-63.
Abstrakt:	The bicuspid aortic valve (BAV) is a congenital heart disease. Aim: The aim of study was to evaluate the assessment of atherosclerosis risk factors in adult patients with bicuspid aortic valve compared against 30 healthy, age and sex matched volunteers. Materials and Methods: Thirty patients (22 males, 8 females) at an average age of 27.00 ±10.6 years were compared against thirty healthy, age and sex matched volunteers. The arterial blood pressure, lipid profile, fasting glucose, inflammation markers and the lifestyle factors were analysed. Results: Patients with bicuspid aortic valve have a higher level of glucose (4.95 vs 4.7 mmol / l, p = 0.026) and fibrinogen (2.25 vs. 1.98 g / l, p = 0.001) compared to the control group. In the group of patients with bicuspid aortic valve there was no hypertension, diabetes, tachycardia, stress exposure, alcohol abuse and a positive family history of cardiovascular diseases. Conclusions: The patients with bicuspid aortic valve have higher glucose and fibrinogen levels and they need systematic checking to reduce cardiovascular risk factors. (© 2019 MEDPRESS.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu